Company: PTHS
Filing Date: 2025-05-27
Form Type: DEFM14C
Source: 0001140361-25-020509
Chunk: 256

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-05-27
Form: DEFM14C
Chunk 256
---
 on LNHC relative to the other participants in the industry or industries in which LNHC operates); |

| • | changes or events after the date of the Merger Agreement affecting the industry or industries in which LNHC operates generally (except to the extent those changes or events have a disproportionate effect on LNHC relative to the other participants in the industry or industries in which LNHC operates); |

| • | changes after the date of the Merger Agreement in GAAP or requirements or the interpretation thereof (except to the extent those changes have a disproportionate effect on LNHC relative to the other participants in the industry or industries in which LNHC operates); |

| • | changes after the date of the Merger Agreement in laws, rules or regulations of general applicability or interpretations thereof by any governmental entity (except to the extent those changes have a disproportionate effect on LNHC relative to the other participants in the industry or industries in which LNHC operates); |

| • | any natural disaster, epidemic, pandemic or other disease outbreak or any outbreak of major hostilities or any act of terrorism (except to the extent those changes or events have a disproportionate effect on LNHC relative to the other participants in the industry or industries in which LNHC operates); |

| • | the execution, delivery, announcement or performance of the obligations under the Merger Agreement or the announcement, pendency or anticipated consummation of the transactions contemplated by the Merger Agreement; |

| • | any failure by LNHC to meet any internal guidance, budgets, plans or forecasts of its revenues, earnings or other financial performance or results of operations (but not the underlying cause of such changes or failures, unless such changes or failures would otherwise be excepted from the definition of material adverse effect); |

141

TABLE OF CONTENTS

| • | the taking of any action, or the failure to take any action, by LNHC that is expressly required under the terms of the Merger Agreement; or |

| • | any equityholder or derivative litigation arising from or relating to the Merger Agreement or the transactions contemplated by the Merger Agreement. |

With respect to Channel, a “material adverse effect” for purposes of the Merger Agreement means any Effect that, individually or in the aggregate with all other Effects that have occurred through the date of determination of the occurrence of a material adverse effect, has had, or is reasonably likely to have, a material adverse effect on the business, assets and liabilities, financial condition or results of operations of Channel and its subsidiaries, taken as a whole;